These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19067236)

  • 1. The 4154delA mutation carriers in the BRCA1 gene share a common ancestry.
    Ozolina S; Sinicka O; Jankevics E; Inashkina I; Lubinski J; Gorski B; Gronwald J; Nasedkina T; Fedorova O; Lyubchenko L; Tihomirova L
    Fam Cancer; 2009; 8(1):1-4. PubMed ID: 19067236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haplotypes of the I157T CHEK2 germline mutation in ethnically diverse populations.
    Kaufman B; Laitman Y; Gronwald J; Winqvist R; Irmejs A; Lubinski J; Pylkäs K; Gardovskis J; Miklasevics E; Friedman E
    Fam Cancer; 2009; 8(4):473-8. PubMed ID: 19609724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The deletion of exons 3-5 of BRCA1 is the first founder rearrangement identified in breast and/or ovarian cancer Spanish families.
    Palanca S; de Juan I; Perez-Simó G; Barragán E; Chirivella I; Martínez E; Fuster O; Bolufer P
    Fam Cancer; 2013 Mar; 12(1):119-23. PubMed ID: 23117300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haplotype of the C61G BRCA1 mutation in Polish and Jewish individuals.
    Kaufman B; Laitman Y; Gronwald J; Lubinski J; Friedman E
    Genet Test Mol Biomarkers; 2009 Aug; 13(4):465-9. PubMed ID: 19594371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for an ancient BRCA1 mutation in breast cancer patients of Yoruban ancestry.
    Zhang B; Fackenthal JD; Niu Q; Huo D; Sveen WE; DeMarco T; Adebamowo CA; Ogundiran T; Olopade OI
    Fam Cancer; 2009; 8(1):15-22. PubMed ID: 18679828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy.
    Cini G; Mezzavilla M; Della Puppa L; Cupelli E; Fornasin A; D'Elia AV; Dolcetti R; Damante G; Bertok S; Miolo G; Maestro R; de Paoli P; Amoroso A; Viel A
    BMC Med Genet; 2016 Feb; 17():11. PubMed ID: 26852130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel BRCA1 deleterious mutation (c.1918C>T) in familial breast and ovarian cancer syndrome who share a common ancestry.
    Gabaldó Barrios X; Sarabia Meseguer MD; Alonso Romero JL; Marín Vera M; Marín Zafra G; Sánchez Henarejos P; Sánchez Bermúdez AI; Ruiz Espejo F
    Fam Cancer; 2014 Sep; 13(3):431-5. PubMed ID: 24633894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haplotype analysis and ancient origin of the BRCA1 c.4035delA Baltic founder mutation.
    Janavičius R; Rudaitis V; Feng BJ; Ozolina S; Griškevičius L; Goldgar D; Tihomirova L
    Eur J Med Genet; 2013 Mar; 56(3):125-30. PubMed ID: 23274591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of two BRCA1 mutations, 4154delA and 5382insC, in Latvia.
    Tikhomirova L; Sinicka O; Smite D; Eglitis J; Hodgson SV; Stengrevics A
    Fam Cancer; 2005; 4(2):77-84. PubMed ID: 15951956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haplotype analysis of two recurrent genomic rearrangements in the BRCA1 gene suggests they are founder mutations for the Greek population.
    Pertesi M; Konstantopoulou I; Yannoukakos D
    Clin Genet; 2011 Oct; 80(4):375-82. PubMed ID: 20840220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily).
    Russo A; Calò V; Augello C; Bruno L; Agnese V; Schirò V; Barbera F; Cascio S; Foddai E; Badalamenti G; Intrivici C; Cajozzo M; Gulotta G; Surmacz E; Colucci G; Gebbia N; Bazan V
    Ann Oncol; 2007 Jun; 18 Suppl 6():vi99-102. PubMed ID: 17591844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haplotype analysis of the internationally distributed BRCA1 c.3331_3334delCAAG founder mutation reveals a common ancestral origin in Iberia.
    Tuazon AMA; Lott P; Bohórquez M; Benavides J; Ramirez C; Criollo A; Estrada-Florez A; Mateus G; Velez A; Carmona J; Olaya J; Garcia E; Polanco-Echeverry G; Stultz J; Alvarez C; Tapia T; Ashton-Prolla P; ; Vega A; Lazaro C; Tornero E; Martinez-Bouzas C; Infante M; De La Hoya M; Diez O; Browning BL; ; Rannala B; Teixeira MR; Carvallo P; Echeverry M; Carvajal-Carmona LG
    Breast Cancer Res; 2020 Oct; 22(1):108. PubMed ID: 33087180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer.
    Baudi F; Quaresima B; Grandinetti C; Cuda G; Faniello C; Tassone P; Barbieri V; Bisegna R; Ricevuto E; Conforti S; Viel A; Marchetti P; Ficorella C; Radice P; Costanzo F; Venuta S
    Hum Mutat; 2001 Aug; 18(2):163-4. PubMed ID: 11462242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations.
    Hamel N; Feng BJ; Foretova L; Stoppa-Lyonnet D; Narod SA; Imyanitov E; Sinilnikova O; Tihomirova L; Lubinski J; Gronwald J; Gorski B; Hansen Tv; Nielsen FC; Thomassen M; Yannoukakos D; Konstantopoulou I; Zajac V; Ciernikova S; Couch FJ; Greenwood CM; Goldgar DE; Foulkes WD
    Eur J Hum Genet; 2011 Mar; 19(3):300-6. PubMed ID: 21119707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?
    Russo A; Calò V; Bruno L; Schirò V; Agnese V; Cascio S; Foddai E; Fanale D; Rizzo S; Di Gaudio F; Gulotta E; Surmacz E; Di Fede G; Bazan V
    Breast Cancer Res Treat; 2009 Jan; 113(1):67-70. PubMed ID: 18228134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Founder mutation in the BRCA1 gene in Malay breast cancer patients from Singapore.
    Lee AS; Ho GH; Oh PC; Balram C; Ooi LL; Lim DT; Wong CY; Hong GS
    Hum Mutat; 2003 Aug; 22(2):178. PubMed ID: 12872263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haplotype analyses of the c.1027C>T and c.2167_2168delAT recurrent truncating mutations in the breast cancer-predisposing gene PALB2.
    Catucci I; Casadei S; Ding YC; Volorio S; Ficarazzi F; Falanga A; Marchetti M; Tondini C; Franchi M; Adamson A; Mandell J; Walsh T; Olopade OI; Manoukian S; Radice P; Ricker C; Weitzel J; King MC; Peterlongo P; Neuhausen SL
    Breast Cancer Res Treat; 2016 Nov; 160(1):121-129. PubMed ID: 27624329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-founder BRCA1 mutations in Russian breast cancer patients.
    Iyevleva AG; Suspitsin EN; Kroeze K; Gorodnova TV; Sokolenko AP; Buslov KG; Voskresenskiy DA; Togo AV; Kovalenko SP; Stoep Nv; Devilee P; Imyanitov EN
    Cancer Lett; 2010 Dec; 298(2):258-63. PubMed ID: 20727672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strong founder effects in BRCA1 mutation carrier breast cancer patients from Latvia. Mutation in brief no. 258. Online.
    Csokay B; Tihomirova L; Stengrevics A; Sinicka O; Olah E
    Hum Mutat; 1999; 14(1):92. PubMed ID: 10447273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation.
    Bergman A; Einbeigi Z; Olofsson U; Taib Z; Wallgren A; Karlsson P; Wahlström J; Martinsson T; Nordling M
    Eur J Hum Genet; 2001 Oct; 9(10):787-93. PubMed ID: 11781691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.